Many companies are choosing to outsource the manufacture of their highly potent compounds. A provider of contract pharma services in high potent manufacturing, Alkermes Contract Pharma Services, outlines elements that should be considered when outsourcing secondary processing (i.e. dosage form transfer, scale-up and commercial manufacture) of a highly potent product.
- Joint Risk Assessment During Technical Transfer – A Framework for Donor and Recipient Companies
- Alkermes’ successful approach to commercial scale final dosage manufacture of drug product containing highly potent API
- Pharmaceutical Outsourcing - key success factors
- Application of a partner-driven approach in winning and maintaining outsourced pharmaceutical business